Global Injection Devices for Biological Drugs Market is expected to grow at a high CAGR during the forecast period 2024-2031

Biological drug injection devices are tools designed for the delivery of biological medications like proteins, antibodies, and vaccines into the body via injection. 

The range of these devices includes syringes, auto-injectors, and pen injectors. They play a crucial role in guaranteeing precise dosage and enhancing the convenience and efficiency of the administration process.

 

For More Insights Request Free Sample: https://www.datamintelligence.com/download-sample/injection-devices-for-biological-drugs-market

 

Market Segmentation 

By Type of Product 

  • Glass material 

  • Plastic material 

By Site of Administration 

  • Skin 

  • Circulatory/Musculoskeletal System  

  • Organs  

  • Central Nervous System  

By Usability 

  • Reusable Pen Injectors 

  • Disposable Pen Injectors 

By Application 

  • Autoimmune Diseases 

  • Hormonal Disorders 

  • Orphan Diseases 

  • Aesthetic Treatment  

  • Other clinical applications  

By End User 

  • Hospitals and Clinics 

  • Home Care Settings 

Market Key Players 

Major players are Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, ELI Lilly and Company, Sandoz (Novartis AG), Terumo Corporation, Teva Pharmaceutical Industries Ltd. and Crossject.

 

Trending Reports